Gapping down
In reaction to disappointing earnings/guidance: FDS -0.7%
M&A news:
In reaction to disappointing earnings/guidance: FDS -0.7%
M&A news:
- SXL -8.2% (to acquire Vitol's crude platform for about $760 mln plus working capital; commenced an underwritten public offering of 21 mln common units pursuant to an effective shelf registration statement on Form S-3 previously filed with the SEC)
- RICE -6% (to acquire Vantage Energy for approximately $2.7 billion; commences a 40 mln share underwritten public offering of common stock)
- MPW -3.9% (to acquire the real estate interests of nine acute care hospitals operated by Steward Health Care System; commences 33.5 mln common stock offering)
Select EU financial related names showing weakness: CS -3.4%, DB -3%, RBS -2.6%, BCS -1.3%
Select oil/gas related names showing early weakness: MRO -2.5%, WLL -2.5%, CHK -2.1%, OAS -1.9%, RIG -1.8%,RDS.A -1.2%
Other news:
Select oil/gas related names showing early weakness: MRO -2.5%, WLL -2.5%, CHK -2.1%, OAS -1.9%, RIG -1.8%,RDS.A -1.2%
Other news:
- CVM -44.4% (receives FDA notice that its Multikine Phase 3 trial placed on clinical holdg)
- MIME -8.7% (commences a registered secondary public offering of 4 mln ordinary shares by selling shareholders)
- CZR -7.5% (announce proposed consensual restructuring plan for CEOC)
- NAT -7.1% (announced an underwritten public offering of 11 mln common shares)
- MYOK -3.7% (announces underwritten public offering of 3,800,000 shares of its common stock)
- AMGN -2.1% (reports Phase 3 KYPROLIS; trial did not meet the primary endpoint)
Analyst comments:
- GILD -1.4% (downgraded to Mkt Perform from Outperform at Leerink Partners)
- DLTR -0.9% (downgraded to Underweight from Neutral at Atlantic Equities)
- CRI -0.8% (downgraded to Market Perform from Outperform at Wells Fargo)
- SJM -0.5% (downgraded to Neutral from Outperform at Credit Suisse)